Common Stock, Shares, Outstanding of Cyclo Therapeutics, Inc. from 31 Dec 2010 to 30 Sep 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cyclo Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 30 Sep 2024.
  • Cyclo Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2024 was 28,768,055, a 49% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Cyclo Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 28,768,055 +9,402,966 +49% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 28,696,028 +13,387,579 +87% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 28,614,384 +18,560,840 +185% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 28,556,072 +20,074,224 +237% 31 Dec 2023 10-K/A 18 Dec 2024 2024 FY
Q3 2023 19,365,089 +10,909,637 +129% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 15,308,449 +6,869,014 +81% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 10,053,544 +1,638,348 +19% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 8,481,848 +77,979 +0.93% 31 Dec 2022 10-K/A 18 Dec 2024 2024 FY
Q3 2022 8,455,452 +2,001,583 +31% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 8,439,435 +2,003,619 +31% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 8,415,196 +2,057,600 +32% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 8,403,869 +3,633,108 +76% 31 Dec 2021 10-K 17 Mar 2023 2022 FY
Q3 2021 6,453,869 -163,422,261 -96% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 6,435,816 -135,235,646 -95% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 6,357,596 -115,207,394 -95% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 4,770,761 +3,555,111 +292% 31 Dec 2020 10-K 11 Mar 2022 2021 FY
Q3 2020 169,876,130 +48,761,140 +40% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 141,671,462 +21,142,138 +18% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 121,564,990 +30,805,666 +34% 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 1,215,650 -89,543,674 -99% 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q3 2019 121,114,990 +33,875,629 +39% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 120,529,324 +33,289,963 +38% 30 Jun 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 90,759,324 +17,767,963 +24% 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 90,759,324 +17,759,963 +24% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 87,239,361 +14,240,000 +20% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 87,239,361 +14,360,000 +20% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 72,991,361 +112,000 +0.15% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 72,999,361 +6,046,832 +9% 31 Dec 2017 10-K 15 Mar 2019 2018 FY
Q3 2017 72,999,361 +6,046,832 +9% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 72,879,361 +6,209,014 +9.3% 30 Jun 2017 10-Q 11 Aug 2017 2017 Q2
Q1 2017 72,879,361 +14,209,014 +24% 31 Mar 2017 10-Q 12 May 2017 2017 Q1
Q4 2016 66,952,529 +8,282,182 +14% 31 Dec 2016 10-K 16 Apr 2018 2017 FY
Q3 2016 66,952,529 +8,282,182 +14% 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 66,670,347 +12,214,465 +22% 30 Jun 2016 10-Q 12 Aug 2016 2016 Q2
Q1 2016 58,670,347 +4,214,465 +7.7% 31 Mar 2016 10-Q 16 May 2016 2015 Q1
Q4 2015 58,670,347 +4,249,465 +7.8% 31 Dec 2015 10-K 17 Mar 2017 2016 FY
Q3 2015 58,670,347 +4,389,465 +8.1% 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 54,455,882 +2,000,000 +3.8% 30 Jun 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 54,455,882 +6,000,000 +12% 31 Mar 2015 10-Q 15 May 2015 2015 Q1
Q4 2014 54,420,882 +16,965,000 +45% 31 Dec 2014 10-K 30 Mar 2016 2015 FY
Q3 2014 54,280,882 +16,825,000 +45% 30 Sep 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 52,455,882 +15,566,347 +42% 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 48,455,882 +11,566,347 +31% 31 Mar 2014 10-Q 09 May 2014 2014 Q1
Q4 2013 37,455,882 +566,347 +1.5% 31 Dec 2013 10-K 27 Mar 2015 2014 FY
Q3 2013 37,455,882 +566,347 +1.5% 30 Sep 2013 10-Q 13 Nov 2013 2013 Q3
Q2 2013 36,889,535 +314,465 +0.86% 30 Jun 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 36,889,535 +314,465 +0.86% 31 Mar 2013 10-Q 08 May 2013 2013 Q1
Q4 2012 36,889,535 +314,465 +0.86% 31 Dec 2012 10-K 04 Mar 2014 2013 FY
Q3 2012 36,889,535 +641,938 +1.8% 30 Sep 2012 10-Q 13 Nov 2012 2012 Q3
Q2 2012 36,575,070 +1,063,104 +3% 30 Jun 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 36,575,070 31 Mar 2012 10-Q 21 May 2012 2012 Q1
Q4 2011 36,575,070 +1,166,248 +3.3% 31 Dec 2011 10-K 14 Mar 2013 2012 FY
Q3 2011 36,247,597 30 Sep 2011 10-Q/A 23 Feb 2012 2011 Q3
Q2 2011 35,511,966 30 Jun 2011 10-Q 15 Aug 2011 2011 Q2
Q4 2010 35,408,822 31 Dec 2010 10-K 16 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.